BU BÖLÜM HAKKINDA
In this episode of The Connect Current, we sit down with Niren Shah, PharmD, MBA, Co-founder and CEO of Cove Therapeutics, to explore one of the biggest challenges in genetic medicine: delivery. Niren shares how Cove is developing non-lipid, non-viral biodegradable polymeric nanoparticles designed to overcome key limitations in the field, including efficiency, safety, manufacturing, redosing, and larger genetic payloads. The conversation dives into Cove’s platform approach, what it takes to build a biotech company around difficult science, and why the company’s next chapter as one of Connect’s 2026 Cool Companies reflects the strength of San Diego’s growing life sciences ecosystem.
Recorded at UC San Diego Park & Market:
https://parkandmarket.ucsd.edu/
Learn more about Cove Therapeutics:
https://covetx.com/
